{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-270314","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2024-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.440290+00:00","generated_at":"2026-05-29T08:46:14.654790+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Beam Therapeutics appoints Chirfi Guindo to board of directors","bullets":["Chirfi Guindo, chief marketing officer of Human Health at Merck, appointed to Beam's board.","Board expanded from seven to eight members; Guindo elected as Class I director effective Dec. 2, 2024.","Guindo brings 25+ years at Merck and Biogen, expertise in global strategy and commercial operations.","He will serve on the Compensation Committee of the board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-270314","json":"https://secwatch.observer/filing/0001193125-24-270314.json","markdown":"https://secwatch.observer/filing/0001193125-24-270314.md","text":"https://secwatch.observer/filing/0001193125-24-270314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/0001193125-24-270314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524270314/d912801d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T08:46:14.654790+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}